Recombinant human papillomavirus quadrivalent vaccine (Chengdu institute of biological products)

四价重组人乳头瘤病毒疫苗（成都生物制品研究所）

Report date: 2025/10/11 16:26:46

Base Information

Drug NameRecombinant human papillomavirus quadrivalent vaccine (Chengdu institute of biological products)
Drug Alias NameTetravalent HPV vaccine (Chengdu institute of biological products)Human papillomavirus (types 6, 11, 16, 18) vaccine (Chengdu institute of biological products)Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Chengdu institute of biological products)爱薇佳
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsPapillomavirus Infections
Approved Indications in ChinaPapillomavirus Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2025/09/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Institute Of Biological Products Co Ltd
Inactive CompaniesNational Vaccine and Serum Institute, ChinaBeijing Institute Of Biological Products Co Ltd
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A